Cure8 research brief
Accurate measurement of physical activity matters because it’s linked to symptoms, fitness, and overall health.
This study suggests the common paper questionnaire (GLTEQ HCS) may be less reliable for measuring moderate-to-vigorous activity in people with Crohn’s disease than in healthy adults, which could affect studies or care plans that rely only on self-report.
Adult patients with Crohn’s disease, clinicians tracking patient activity, researchers studying physical activity in IBD, and rehabilitation professionals.
This study tested whether the Godin Leisure-Time Exercise Questionnaire Health Contribution Score (GLTEQ HCS) reflects moderate-to-vigorous physical activity (MVPA) measured by a waist-worn ActiGraph accelerometer in adults with Crohn’s disease (CD) and in healthy control participants.
Researchers had 38 adults with CD and 41 controls wear an accelerometer for 7 days and complete the GLTEQ.
In healthy controls the GLTEQ HCS showed modest correlation with accelerometer-measured MVPA and differences across activity categories; in the CD group the evidence of validity was weaker and did not reach statistical significance except when the GLTEQ was dichotomized into “active” versus “insufficiently active.” The paper’s main point: the GLTEQ HCS has
context-dependent, modest construct validity for estimating MVPA—stronger in healthy controls than in adults with Crohn’s disease, and somewhat better when using a dichotomous cut-point.
If you use the GLTEQ in clinical practice or research with people who have CD, interpret scores cautiously and consider objective activity monitoring when precise MVPA measurement is needed.
Structured content depth: abstract — this brief summarizes the journal article abstract from PubMed and does not reflect review of the full published paper beyond the provided abstract. The study sample was modest in size and predominantly female; results were context-dependent and stronger when GLTEQ scores were dichotomized.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Non-invasive biomarkers that reflect mucosal inflammation and systemic disease activity could help reduce reliance on frequent endoscopy and guide monitoring for people with Crohn’s disease or ulcerative colitis.
Non-invasive urine biomarkers could make diagnosis and disease-activity monitoring easier and less invasive for people with IBD. Identifying metabolites linked to UC activity may help tailor monitoring without frequent...
Sarcopenia is common in Crohn's disease and is linked to worse outcomes; a simple GNRI-based prediction tool could help identify at-risk patients without routine CT scanning.
